Table 2 Distribution of relevant factors in male patients according to clinical stage
From: The development and validation of oral cancer staging using administrative health data
Male | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Stage I versus II-IV | Stage I-II versus III-IV | Stage I-III versus IV | |||||||||
Stage I | Stage I-II | Stage I-III | |||||||||
Total | N | % | P-value | N | % | P-value | N | % | P-value | ||
Age | 0.0056 | 0.0423 | 0.9638 | ||||||||
20-44 | 265 | 42 | 15.85 | 78 | 29.43 | 164 | 61.89 | ||||
45-64 | 610 | 121 | 19.84 | 207 | 33.93 | 380 | 62.30 | ||||
> = 65 | 120 | 36 | 30.00 | 51 | 42.50 | 76 | 63.33 | ||||
Site | <.0001 | <.0001 | <.0001 | ||||||||
Lip | 48 | 13 | 27.08 | 19 | 39.58 | 38 | 79.17 | ||||
Tongue | 307 | 84 | 27.36 | 133 | 43.32 | 233 | 75.90 | ||||
Gingiva | 83 | 5 | 6.02 | 13 | 15.66 | 25 | 30.12 | ||||
Floor of mouth | 26 | 11 | 42.31 | 15 | 57.69 | 19 | 73.08 | ||||
Others | 531 | 86 | 16.20 | 156 | 29.38 | 305 | 57.44 | ||||
Treatment | <.0001 | <.0001 | <.0001 | ||||||||
S | 346 | 142 | 40.57 | 215 | 61.43 | 305 | 87.14 | ||||
RT | 5 | 2 | 40.00 | 2 | 40.00 | 2 | 40.00 | ||||
CT | 302 | 18 | 5.96 | 38 | 12.58 | 109 | 36.09 | ||||
S + RT | 60 | 11 | 18.33 | 18 | 30.00 | 43 | 71.67 | ||||
S + CT | 139 | 18 | 12.95 | 43 | 30.94 | 92 | 66.19 | ||||
RT + CT | 69 | 0 | 0.00 | 4 | 5.80 | 23 | 33.33 | ||||
S + RT + CT | 70 | 8 | 11.43 | 16 | 22.86 | 46 | 65.71 | ||||